SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

ERNA

Ernexa Therapeutics Inc.
NASDAQHealth Care

Latest close: 2.09 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell◆Adverse 8-K filing◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 15, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Sep 16, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  3. Sep 16, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record1,36819 flagged findings
Reported transactions (Form 4)59since Jun 21, 2023 · and 8 other holdings
Corporate events (8-K)30since Dec 20, 2023

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

Identity

Formerly traded as BTX.

Listing notice in force

The exchange has notified the company that it fails a continued-listing requirement (8-K, item 3.01 of Mar 20, 2026).

Deadline: Sep 14, 2026 · passed

  • minimum bid price · Nasdaq, rule 5550(a)(2) · notice of Mar 18, 2026 · pending · deadline Sep 14, 2026 (derived from the rule, not confirmed in the text) · first period expired; a second 180-day period may exist that is not on record

The other times

Of the 30 issuers that received this notice 1 to 2 years ago, within the following 365 days 16 regained compliance, 23 did a reverse split and 1 filed a Form 25 (delisting). An issuer can be in more than one group.

Measured on our own SEC documents: the cohort is the issuers whose notices we read, not the whole market. Historical distribution, not a prediction.

Open the 8-K at the SEC

Reverse splits in 5 years

3 reverse splits in 5 years (1:20 on Oct 17, 2022, 1:15 on Jun 12, 2025, 1:25 on May 4, 2026) · 1:7500 cumulative

The other times: of 247 securities that repeated a reverse split in 5 years, a year later the median was worth 0.10× the price on the day of the split; 189 lost more than half and 21 rose (243 with a price a year later).

Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 1,368)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 15, 268-K ↗Current report · Communication to the market new
  • Sep 22, 26Form 3 ↗Insider transaction
  • Sep 16, 268-K ↗Current report · Communication to the market
  • Sep 16, 268-K ↗Current report · A senior executive left or was appointed
  • Insider transaction · 6 Form 4 filingsshow all 6hide
  • Aug 27, 26Form 3 ↗Insider transaction
  • Aug 6, 2610-Q ↗Quarterly report
  • Jul 2, 268-K ↗Current report · Communication to the market
  • Jul 2, 268-K ↗Current report · Shareholder vote results
  • Jun 26, 268-K ↗Current report · A senior executive left or was appointed
  • May 20, 26SCHEDULE 13G/A ↗Passive stake · amendment
  • May 15, 26SCHEDULE 13G/A ↗Passive stake · Freebird Partners LP · 9.9% · event on Feb 10, 26 · amendment
  • May 15, 26SCHEDULE 13G/A ↗Passive stake · John D. Halpern · 5.6% · event on Feb 10, 26 · amendment
  • May 14, 26SCHEDULE 13G ↗Passive stake · Clear Street LLC · 12.8% · event on May 5, 26
  • May 14, 26SCHEDULE 13G ↗Passive stake · Bleichroeder LP · 6.9% · event on Mar 31, 26
  • May 13, 26SCHEDULE 13G/A ↗Passive stake · Shameek Konar · 9.7% · event on Feb 10, 26 · amendment
  • May 11, 26DEFA14A ↗Shareholder meeting and votes
  • May 11, 26DEF 14A ↗Shareholder meeting and votes
  • May 11, 2610-Q ↗Quarterly report
  • May 4, 268-K ↗Current report · Bylaws or fiscal year change

1,368 filings on record, the oldest from Feb 14, 94.

Listing the 25 most recent filings of the 1,368 on record.

8-Ks, explained

Stress27Structure102Governance109
  • Sep 16, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Jun 26, 26GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Mar 20, 26StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Feb 11, 26StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Jul 7, 25GovernanceAuditor change filing (8-K Item 4.01)+1 more in the same filing8-K 4.01 ↗
  • Jun 9, 25StructureSold unregistered shares+1 more in the same filing8-K 3.02 ↗
  • Structure3 material agreements entered2025show all 3hide
    • Apr 3, 25StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
    • Mar 24, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
    • Mar 12, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Jan 10, 25StressListing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
  • Jan 3, 25StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Oct 29, 24StructureEntered a material agreement+4 more in the same filing8-K 1.01 ↗
  • Sep 27, 24StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Sep 25, 24StructureSold unregistered shares+4 more in the same filing8-K 3.02 ↗

5 older filings not shown · The record reaches back to Aug 23, 04.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

  • Sep 23, 24StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Mar 22, 24StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Jan 19, 24StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Oct 5, 23StressListing notice (8-K 3.01)+2 more in the same filing8-K 3.01 ↗
  • Aug 10, 23StressListing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
  • Jan 10, 23StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Jan 5, 22StressRestructuring plan with committed costs8-K 2.05 ↗

The full record holds 27 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • Clear Street LLC12.8%May 5, 26SCHEDULE 13G ↗
  • Freebird Partners LP9.9%Feb 10, 26SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
  • Shameek Konar9.7%Feb 10, 26SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
  • Bleichroeder LP6.9%Mar 31, 26SCHEDULE 13G ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
  • John D. Halpern5.6%Feb 10, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
show 2 more holdershide
  • Nicholas Jason Singer4.9%Dec 31, 24SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
  • IAF, LLC4.1%Jul 28, 25SCHEDULE 13G/A ↗2 earlier filings

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Feb 10, 26Buy$2.0MCharles Cherington↗
  • Jun 9, 25Buy$2.2MCharles Cherington↗
  • Apr 2, 25Buy$394KCharles Cherington↗
  • Oct 29, 24Buyamount n/aCharles Cherington↗
  • Oct 29, 24Buyamount n/aCharles Cherington↗
  • Oct 29, 24Buyamount n/aCharles Cherington↗
  • Oct 29, 24Buyamount n/aCharles Cherington↗
  • Oct 29, 24Buyamount n/aCharles Cherington↗
  • Sep 24, 24Buyamount n/aCharles Cherington↗
  • Sep 24, 24Buyamount n/aCharles Cherington↗
  • Sep 24, 24Buyamount n/aCharles Cherington↗
  • Sep 24, 24Buyamount n/aCharles Cherington↗

There is 1 more transaction in this stretch.

Stock compensation, tax and giftsshow the 6 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Jun 21, 25Compensationamount n/aSandra M GurrolaSr. VP of Finance↗
  • Oct 29, 24Other$1.4MCharles Cherington↗
  • Jun 21, 24Compensationamount n/aSandra M GurrolaSr. VP of Finance↗
  • Jun 21, 24Tax$349Sandra M GurrolaSr. VP of Finance↗
  • Jun 21, 23Compensationamount n/aSandra M GurrolaVice President of Finance↗
  • Jun 21, 23Tax$444Sandra M GurrolaVice President of Finance↗

The full record holds 19 transactions and goes back to Dec 2, 22.

Its sector and its market

Ernexa Therapeutics Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Ernexa Therapeutics Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Ernexa Therapeutics Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
Series with incidents in the period; the chart shows what could be kept.
SEC records
1,368 documents on file, from Feb 14, 1994 to Oct 15, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.